Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,476 | 17 | 86.6% |
| Food and Beverage | $2,083 | 141 | 11.7% |
| Travel and Lodging | $152.78 | 3 | 0.9% |
| Consulting Fee | $150.00 | 1 | 0.8% |
| Education | $11.52 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $13,336 | 45 | $0 (2024) |
| AbbVie Inc. | $2,375 | 4 | $0 (2021) |
| Braeburn Inc. | $274.48 | 11 | $0 (2024) |
| Allergan Inc. | $261.05 | 13 | $0 (2017) |
| Alkermes, Inc. | $254.63 | 8 | $0 (2024) |
| Lundbeck LLC | $162.03 | 17 | $0 (2024) |
| Neos Therapeutics, LP | $154.51 | 4 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $137.45 | 8 | $0 (2024) |
| Titan Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $118.53 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $490.81 | 26 | Braeburn Inc. ($138.84) |
| 2023 | $1,641 | 7 | Otsuka America Pharmaceutical, Inc. ($1,404) |
| 2022 | $4,905 | 7 | Otsuka America Pharmaceutical, Inc. ($4,905) |
| 2021 | $8,296 | 12 | Otsuka America Pharmaceutical, Inc. ($5,920) |
| 2020 | $790.00 | 2 | Otsuka America Pharmaceutical, Inc. ($790.00) |
| 2019 | $248.60 | 18 | Otsuka America Pharmaceutical, Inc. ($51.26) |
| 2018 | $424.71 | 23 | Titan Pharmaceuticals, Inc. ($125.00) |
| 2017 | $1,076 | 71 | Allergan Inc. ($261.05) |
All Payment Transactions
166 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $19.63 | General |
| 10/01/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: Opioid Use Disorder | ||||||
| 09/23/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: OUD | ||||||
| 09/12/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: Opioid Use Disorder | ||||||
| 09/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: CNS | ||||||
| 09/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.78 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Neuroscience | ||||||
| 08/27/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Neuropsychiatry | ||||||
| 07/01/2024 | Noven Therapeutics, LLC | Secuado (Drug), Xelstrym | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: CNS Psychiatry | ||||||
| 06/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: PSYCHIATRY | ||||||
| 06/10/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Neuroscience | ||||||
| 05/30/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $0.45 | General |
| Category: Opioid Use Disorder | ||||||
| 05/22/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: Opioid Use Disorder | ||||||
| 04/23/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $1.87 | General |
| Category: Opioid Use Disorder | ||||||
| 04/02/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $1.68 | General |
| Category: Opioid Use Disorder | ||||||
| 03/27/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Neuroscience | ||||||
| 03/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/25/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $109.60 | General |
| Category: Opioid Use Disorder | ||||||
| 02/21/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Neurology | ||||||
| 02/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: Neuropsychiatry | ||||||
| 02/13/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $1.77 | General |
| Category: Opioid Use Disorder | ||||||
| 02/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 96 | 238 | $38,693 | $17,573 |
| 2022 | 5 | 128 | 341 | $55,346 | $24,445 |
| 2021 | 8 | 213 | 447 | $67,664 | $29,493 |
| 2020 | 11 | 572 | 1,462 | $216,413 | $88,070 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 46 | 161 | $21,252 | $10,111 | 47.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 32 | $5,632 | $2,908 | 51.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 19 | $5,491 | $2,342 | 42.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 19 | 26 | $6,318 | $2,213 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 51 | 162 | $21,384 | $10,080 | 47.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 71 | $12,496 | $5,424 | 43.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 25 | $7,225 | $3,778 | 52.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 52 | $6,708 | $2,758 | 41.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 23 | 31 | $7,533 | $2,406 | 31.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 66 | 205 | $27,060 | $13,689 | 50.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 18 | 44 | $7,744 | $3,336 | 43.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 20 | $5,780 | $3,022 | 52.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 51 | $6,579 | $2,573 | 39.1% |
| 90834 | Psychotherapy, 45 minutes | Facility | 2021 | 31 | 54 | $7,344 | $2,482 | 33.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 26 | 31 | $7,533 | $2,365 | 31.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 24 | 31 | $2,852 | $1,084 | 38.0% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2021 | 11 | 11 | $2,772 | $941.08 | 33.9% |
| 90834 | Psychotherapy, 45 minutes | Facility | 2020 | 62 | 385 | $52,360 | $21,456 | 41.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 60 | 294 | $37,926 | $16,154 | 42.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 62 | 68 | $19,652 | $10,055 | 51.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 99 | 263 | $24,196 | $9,133 | 37.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 68 | 138 | $18,216 | $7,392 | 40.6% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2020 | 74 | 74 | $18,648 | $6,723 | 36.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 64 | 83 | $20,169 | $6,667 | 33.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 26 | 69 | $12,144 | $5,439 | 44.8% |
About Dr. Andrew Skinner, MD
Dr. Andrew Skinner, MD is a Psychiatry healthcare provider based in Anderson, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578594826.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Skinner, MD has received a total of $17,872 in payments from pharmaceutical and medical device companies, with $490.81 received in 2024. These payments were reported across 166 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($15,476).
As a Medicare-enrolled provider, Skinner has provided services to 1,009 Medicare beneficiaries, totaling 2,488 services with total Medicare billing of $159,581. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Anderson, IN
- Active Since 07/05/2006
- Last Updated 08/11/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1578594826
Products in Payments
- ABILIFY MAINTENA (Drug) $13,155
- VRAYLAR (Drug) $2,637
- REXULTI (Drug) $282.32
- BRIXADI (Drug) $274.48
- Adzenys XR-ODT (Drug) $154.51
- Probuphine (Drug) $135.63
- INGREZZA (Drug) $118.53
- Fanapt (Drug) $99.19
- LATUDA (Drug) $84.26
- SPRAVATO (Drug) $68.58
- Azstarys (Drug) $67.58
- INVEGA SUSTENNA (Drug) $55.96
- ARISTADA (Drug) $50.41
- SUBLOCADE (Drug) $46.48
- VYVANSE (Drug) $41.14
- Auvelity (Drug) $35.89
- Trintellix (Drug) $31.89
- AUSTEDO (Drug) $31.78
- TRINTELLIX (Drug) $31.69
- PERSERIS (Drug) $30.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Anderson
Muhammad Munir, M.d, M.D
Psychiatry — Payments: $99,389
Raymond Kimball, M.d, M.D
Psychiatry — Payments: $5,076
Abdalla Bamashmus, Md, MD
Psychiatry — Payments: $1,568
Craig Buckles, Md, MD
Psychiatry — Payments: $1,542
Urvi Shah, Md, MD
Psychiatry — Payments: $744.94
Dr. Jerry Sheward, M.d, M.D
Psychiatry — Payments: $628.13